Cahill Financial Advisors’s Invesco Pharmaceuticals ETF PJP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-1,701
| Closed | -$132K | – | 616 |
|
|
2021
Q3 | $132K | Buy |
+1,701
| New | +$132K | 0.03% | 250 |
|
|
2021
Q2 | – | Sell |
-2,608
| Closed | -$206K | – | 208 |
|
|
2021
Q1 | $206K | Buy |
+2,608
| New | +$206K | 0.05% | 199 |
|
|
2018
Q4 | – | Sell |
-3,011
| Closed | -$222K | – | 154 |
|
|
2018
Q3 | $222K | Buy |
3,011
+1
| +0% | +$74 | 0.1% | 142 |
|
|
2018
Q2 | $203K | Buy |
+3,010
| New | +$203K | 0.09% | 153 |
|
|
2018
Q1 | – | Sell |
-3,657
| Closed | -$235K | – | 153 |
|
|
2017
Q4 | $235K | Sell |
3,657
-22
| -0.6% | -$1.41K | 0.12% | 124 |
|
|
2017
Q3 | $241K | Sell |
3,679
-1,195
| -25% | -$78.3K | 0.13% | 122 |
|
|
2017
Q2 | $306K | Sell |
4,874
-667
| -12% | -$41.9K | 0.17% | 113 |
|
|
2017
Q1 | $326K | Sell |
5,541
-535
| -9% | -$31.5K | 0.19% | 100 |
|
|
2016
Q4 | $341K | Sell |
6,076
-90
| -1% | -$5.05K | 0.21% | 95 |
|
|
2016
Q3 | $381K | Sell |
6,166
-1,641
| -21% | -$101K | 0.25% | 90 |
|
|
2016
Q2 | $495K | Hold |
7,807
| – | – | 0.35% | 73 |
|
|
2016
Q1 | $470K | Sell |
7,807
-788
| -9% | -$47.4K | 0.35% | 72 |
|
|
2015
Q4 | $602K | Buy |
8,595
+2
| +0% | +$140 | 0.49% | 54 |
|
|
2015
Q3 | $571K | Sell |
8,593
-250
| -3% | -$16.6K | 0.46% | 59 |
|
|
2015
Q2 | $693K | Buy |
8,843
+30
| +0.3% | +$2.35K | 0.52% | 51 |
|
|
2015
Q1 | $674K | Sell |
8,813
-159
| -2% | -$12.2K | 0.51% | 50 |
|
|
2014
Q4 | $597K | Buy |
8,972
+96
| +1% | +$6.39K | 0.46% | 54 |
|
|
2014
Q3 | $565K | Buy |
8,876
+446
| +5% | +$28.4K | 0.45% | 55 |
|
|
2014
Q2 | $515K | Buy |
8,430
+917
| +12% | +$56K | 0.4% | 61 |
|
|
2014
Q1 | $426K | Buy |
7,513
+1,219
| +19% | +$69.1K | 0.36% | 62 |
|
|
2013
Q4 | $337K | Buy |
+6,294
| New | +$337K | 0.29% | 79 |
|